These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 12442457)

  • 21. Significance of anti-interferon-alpha2 and sICAM-1 activities in the sera of viral hepatitis B and C patients treated with human recombinant interferon-alpha2.
    Stancek D; Fuchsberger N; Oltman M; Schmeisser H; Kontsek P; Jahnová E; Hajnická V
    Acta Virol; 2001; 45(5-6):287-92. PubMed ID: 12083327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon therapy of Turkish patients with chronic hepatitis B virus infection.
    Besirbellioglu B; Gul C; Gorenek L; Eyigun CP; Hacibektasoglu A; Van Thiel DH
    Hepatogastroenterology; 1999; 46(25):387-90. PubMed ID: 10228827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of iron metabolism in children with chronic hepatitis B -- prognostic factor in interferon alpha therapy.
    Chrobot A; Chrobot AM; Szaflarska-Szczepanik A
    Med Sci Monit; 2002 Apr; 8(4):CR269-73. PubMed ID: 11951069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic characteristics of hepatitis B virus genotypes as a factor for interferon-induced HBeAg clearance.
    Hou J; Schilling R; Janssen HL; Hansen BE; Heijtink R; Sablon E; Williams R; Lau GK; Schalm SW; Naoumov NV
    J Med Virol; 2007 Aug; 79(8):1055-63. PubMed ID: 17596838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment with interferon gamma versus interferons alfa and gamma in children with chronic hepatitis B.
    Ruiz-Moreno M; Rúa MJ; Moraleda G; Guardia L; Moreno A; Carreño V
    Pediatrics; 1992 Aug; 90(2 Pt 1):254-8. PubMed ID: 1641292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination therapy with hepatitis B vaccine and interferon alfa in chronic hepatitis B.
    Kaymakoğlu S; Demir K; Cakaloğlu Y; Tuncer I; Dinçer D; Gürel S; Okten A
    Am J Gastroenterol; 1999 Mar; 94(3):856-7. PubMed ID: 10086686
    [No Abstract]   [Full Text] [Related]  

  • 27. A longitudinal study of the efficacy of interferon therapy in children with chronic hepatitis B.
    Kacprzak-Bergman I; Zaleska I; Gruszka J; Jasonek J
    Med Sci Monit; 2002 Dec; 8(12):CR805-14. PubMed ID: 12503040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of high dose of recombinant alpha 2b interferon on long term response in chronic hepatitis C and cirrhosis: prospective randomized multicentre study.
    Ascione A; De Luca M; Canestrini C; Di Costanzo GG; Raimondo G; Longo G; Manns MP; Tillmann HL; Forte GB; Rocco P; Biceglia O; Faleo D; Vinelli F; Cela EM; Amitrano L; Addario L; Gigliotti T
    Ital J Gastroenterol Hepatol; 1998 Oct; 30(5):517-23. PubMed ID: 9836109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Topics on type B chronic hepatitis].
    Ishikawa T; Kakumu S
    Nihon Naika Gakkai Zasshi; 2000 Sep; 89(9):1845-9. PubMed ID: 11051660
    [No Abstract]   [Full Text] [Related]  

  • 30. [Individualized treatment strategies for chronic hepatitis B].
    Fan R; Hou JL; Sun J
    Zhonghua Nei Ke Za Zhi; 2012 Oct; 51(10):746-8. PubMed ID: 23290967
    [No Abstract]   [Full Text] [Related]  

  • 31. [Prolonged (24 weeks) treatment of chronic hepatitis type B with recombinant interferon-alpha].
    Matsuda H; Kashiwagi T
    Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):629-34. PubMed ID: 12442457
    [No Abstract]   [Full Text] [Related]  

  • 32. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
    Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet and white blood cell counts during therapy with different types of alpha interferon in patients with chronic viral hepatitis. Investigators of the Alpha Interferon Study Group of Piemonte, Italy.
    Colombatto P; Oliveri F; Leandro G; Baldi M; Capalbo M; Rocca G; Brunetto MR; Bonino F
    Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):441-7. PubMed ID: 9494854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Generation of neutralizing anti-interferon antibodies and factors influencing their production in chronic hepatitis B patients receiving recombinant interferon-alpha treatment].
    Mao QG; Luo KX; Zhang MX; Liu D; Hou JL
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Dec; 23(12):1319-22. PubMed ID: 14678902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current knowledge on treatment of chronic hepatitis B in children.
    Lebensztejn DM; Kaczmarski M
    Med Sci Monit; 2000; 6(1):198-203. PubMed ID: 11208310
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.